Full Coverage

FDA approves Entereg (alvimopan) to restore bowel function

                   
news-medical.net
May 20, 2008
        
Story Timeline:  198 days

The U.S. Food and Drug Administration approved Entereg (alvimopan) today to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than... [read full story]                    

Add Comment
Latest article on this story:

FDA Approves Entereg For Bowel Function Following Surgery

 emaxhealth.com May 23, 2008
First article on this story:

Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of...

 wallstreet-online.de May 20, 2008
Selected publications with coverage of this story:
pharmaceutical-business-review.com redorbit.com nieuwsbank.nl politicalgateway.com emaxhealth.com ad-hoc-news.de pharmiweb.co.uk news-medical.net canadianbusiness.com pharmalot.com earthtimes.org drugpolicycentral.com
RELATED
Found 31 documents:
                   

FDA Approves Entereg For Bowel Function Following Surgery

emaxhealth.com
May 23, 2008
        

FDA approved Entereg (alvimopan) to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. "Entereg will help accelerate their recovery, improve bowel function, and get these patients back on a normal...

                   

FDA Approves Entereg To Help Restore Bowel Function Following Surgery

medicalnewstoday.com
May 22, 2008
        

The U.S. Food and Drug Administration approved Entereg (alvimopan) to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15...

                   

Adolor And GlaxoSmithKline Announce FDA Approval Of Entereg(R) (alvimopan) For The Management Of...

medicalnewstoday.com
May 22, 2008
        

Adolor Corporation (Nasdaq:ADLR) and GlaxoSmithKline (NYSE:GSK) announced that the U.S. Food and Drug Administration has approved Entereg® (alvimopan) capsules to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

Adolor and GlaxoSmithKline win approval for postoperative ileus drug

pharmaceutical-business-review.com
May 22, 2008
        

Adolor and GlaxoSmithKline have announced that the FDA has approved Entereg capsules to help patients regain gastrointestinal function earlier following bowel resection surgery. Entereg is indicated to accelerate upper and lower gastrointestinal recovery following partial large or small bowel...

                   

Adolor, GSK Gain U.S. OK for Bowel Drug Entereg

tmcnet.com
May 21, 2008
        

Adolor Corp. and partner GlaxoSmithKline plc won U.S. marketing approval late Tuesday of Entereg (alvimopan) to treat postoperative ileus (POI), a condition that causes severe constipation following large- or small-bowel resection surgery. POI imposes considerable additional expense on the health...

                   

Adolor Corporation Conference Call to Discuss the FDA Approval of Entereg(R) scheduled for 8:30...

yahoo.com
May 21, 2008
        

Adolor Corporation engages in the discovery, development, and commercialization of prescription pain management products primarily in the United States. The company’s lead product candidates include Entereg, which is a small molecule, mu-opioid receptor antagonist designed to block the unwanted...

Out of the Gate: Adolor jumps on Entereg approval (AP)

yahoo.com
May 21, 2008
        

Wednesday May 21, 10:11 am ET Adolor sets annual high after FDA approves constipation drug, but analysts question sales NEW YORK (AP) -- Shares of Adolor Corp. climbed to a fresh annual high Wednesday, after regulators approved its constipation treatment Entereg, but analysts were divided on...

FDA approves GlaxoSmithKline drug (at bizjournals.com)

yahoo.com
May 21, 2008
        

on Tuesday night approved the GlaxoSmithKline drug Entereg, designed to help patients regain gastrointestinal function earlier after bowel surgery. The condition the drug was developed to treat, known as postoperative ileus, affects almost all patients undergoing such surgery and can cause...

FDA OKs postsurgical drug for hospital use

politicalgateway.com
May 21, 2008
        

WASHINGTON, May 21 (UPI) -- The U.S. Food and Drug Administration announced approval of the drug Entereg (alvimopan) to help restore normal bowel function after surgery. The FDA said it approved Entereg for use in hospitalized patients 18 years and older who have undergone partial large or small...

FDA OKs Adolor, GlaxoSmithKline drug Entereg (at bizjournals.com)

yahoo.com
May 21, 2008
        

The Food and Drug Administration Tuesday night approved Adolor Corp.'s Entereg drug that's designed to help patients regain gastrointestinal function earlier following bowel resection surgery. The condition the drug was developed to treat, known as postoperative ileus or POI, affects almost all...

1 2 3 4 next »